Table 6

Clinical and angiographic predictors of optimal myocardial reperfusion in the whole population

OR (95% CI)p
Age0.97 (0.95 to 0.99)0.07
Sex (M)1.30 (0.71 to 2.50)0.42
STUDY variable0.02
EXPORT vs REMEDIA0.61 (0.30 to 1.24)0.17
PIHRATE vs REMEDIA0.47 (0.26 to 0.80)0.007
Diabetes0.40 (0.18 to 0.96)0.03
IIb/IIIa inhibitors1.20 (0.70 to 2.11)0.40
Time-to-treatment subgroups0.80 (0.60 to 1.15)0.10
MVD0.80 (0.50 to 1.32)0.41
LAD as infarct-related artery0.32 (0.21 to 0.61)<0.001
TIMI flow 0–10.68 (0.33 to 1.43)0.31
TS1.21 (1.00 to 1.48)0.05
TA2.41 (1.44 to 4.00)0.001
RVD ≥4 mm1.42 (0.60 to 3.01)0.40
Distal embolisation0.41 (0.15 to 1.32)0.12
  • LAD, left anterior descending artery; MVD, multivessel disease; RVD, reference vessel diameter; TA, thrombus aspiration; TS, thrombus score.